UNICYCIVE THERAPEUTICS, INC. Compensation Expense, Excluding Cost of Good and Service Sold
UNICYCIVE THERAPEUTICS, INC. (UNCY) reported Compensation Expense, Excluding Cost of Good and Service Sold of $800 for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold · last filed 2024-05-13
- UNICYCIVE THERAPEUTICS, INC. compensation expense, excluding cost of good and service sold for the quarter ending 2024-03-31 was $800.00.
- UNICYCIVE THERAPEUTICS, INC. compensation expense, excluding cost of good and service sold for the quarter ending 2023-12-31 was -$1.00M.
- UNICYCIVE THERAPEUTICS, INC. compensation expense, excluding cost of good and service sold for fiscal 2023 was $1.00M.
| Period end | Compensation Expense, Excluding Cost of Good and Service Sold 3 month | Compensation Expense, Excluding Cost of Good and Service Sold 6 month | Compensation Expense, Excluding Cost of Good and Service Sold 9 month | Compensation Expense, Excluding Cost of Good and Service Sold 12 month |
|---|---|---|---|---|
| 2024-03-31 | $800.00 10-Q · filed 2024-05-13 | -$999.20K derived: sum of 2 quarters · filed 2024-05-13 | ||
| 2023-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $1.00M 10-K · filed 2024-03-28 | ||
| 2023-09-30 | $2.00M 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |